Biomarin Pharmaceutical

BMRN

NASDAQHealth Care

Income Statement

Total Revenue$2.85B

Gross Profit$2.27B

Operating Income$484.21M

EBITDA$650.86M

EBIT$554.43M

Pre-tax Income$385.59M

Net Income$426.86M

Net Cash$3.52B

Cash Equivalent$834.36M

Total Debt$841.67M

Net Debt$-2.68B

Book Value$5.36B

Net Cash Per Share18.23

Book Value Per Share28.22

Return on Equity (ROE)+7.54%

Return on Assets (ROA)+6.11%

Return on Invested Capital (ROI)+6.83%

Net Profit Margin+14.96%

Current Ratio5.33

Quick Ratio3.29

Long-Term Debt / Equity0.11